ReviewFrontiers in digital health2025
Synthetic data in medical imaging within the EHDS: a path forward for ethics, regulation, and standards.
Review in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Translation readiness of model-based synthetic tabular data in healthcare: a systematic review and governance audit.Journal of the American Medical Informatics Association : JAMIA · 2026Pooled it
- Tele-Oncology in the Post-Pandemic Era: Clinical Integration, Access Disparities and Medico-Legal Accountability.Current oncology reports · 2026Review
- A Review of Automatic Hair Removal in Dermoscopy Images: From Image Processing to Deep Learning.Journal of imaging informatics in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing availability of medical imaging data offers unprecedented opportunities for advancing artificial intelligence (AI)-driven healthcare. However, strict data protection regulations in the European Union (EU), especially the General Data Protection Regulation (GDPR), present significant challenges to data sharing and reuse. Synthetic data-artificially generated data that mimic the statistical properties of real data without revealing sensitive information-have emerged as a promising solution to bridge this gap. This perspective-style review examines the role of synthetic medical imaging data within the European Health Data Space (EHDS), a policy initiative aimed at enabling secure access to health data across the EU. While we briefly reference cross-cutting privacy-enhancing technologies and one non-imaging comparator to illuminate shared governance issues, our analysis and conclusions are scoped to imaging applications. We discuss the technical foundations and types of synthetic data, their potential to enhance reproducibility and innovation, and the complex ethical and legal concerns surrounding their use. Emphasising the need for a risk-based regulatory framework, we advocate for synthetic data governance that ensures utility, transparency, and accountability, especially when such data are generated using generative AI models. This work contributes to ongoing debates on how synthetic imaging data can support a privacy-preserving, data-driven healthcare ecosystem in Europe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.